Colonial River Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,435
Closed -$244K 249
2025
Q2
$244K Sell
3,435
-151
-4% -$10.3K 0.11% 190
2025
Q1
$249K Sell
3,586
-263
-7% -$21.7K 0.14% 161
2024
Q4
$331K Buy
3,849
+26
+0.7% +$2.81K 0.16% 135
2024
Q3
$455K Hold
3,823
0.23% 103
2024
Q2
$546K Sell
3,823
-218
-5% -$28.9K 0.29% 78
2024
Q1
$519K Sell
4,041
-22
-0.5% -$2.62K 0.29% 84
2023
Q4
$420K Buy
4,063
+186
+5% +$18.4K 0.25% 112
2023
Q3
$353K Sell
3,877
-8,009
-67% -$706K 0.23% 108
2023
Q2
$962K Buy
11,886
+8,854
+292% +$723K 0.63% 40
2023
Q1
$241K Buy
+3,032
New +$215K 0.14% 164

Other funds holding NVO

Colonial River Investments's NVO Position: Q3 2025 in Review

Colonial River Investments sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,435 shares — an estimated $244K sold.

Colonial River Investments first reported a position in NVO in Q1 2023 and held it in 10 quarters. The position peaked at $962K in Q2 2023. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Colonial River Investments reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Colonial River Investments sold 3,435 Novo Nordisk shares in Q3 2025, an estimated $244K.
  • Colonial River Investments first reported a position in Novo Nordisk in Q1 2023 and held it in 10 quarters.
  • Colonial River Investments's Novo Nordisk position peaked at $962K in Q2 2023.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Colonial River Investments's 13F filing for Q3 2025, filed 13 Nov 2025.